We are live on ! Find out more
GS

GTS Securities Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.76%
This Fund
S&P 500
This Quarter Est. Return
+12.86%
1 Year Est. Return
+21.76%
3 Year Est. Return
+68.93%
5 Year Est. Return
10 Year Est. Return
AUM
$54.5B
AUM Growth
-$4.21B
Cap. Flow
-$11.7B
Cap. Flow %
-21.56%
Top 10 Hldgs %
42.9%
Holding
4,632
New
641
Increased
1,096
Reduced
2,006
Closed
864

Sector Composition

Rank Sector Weight
1 Technology 1.48%
2 Consumer Discretionary 0.7%
3 Communication Services 0.47%
4 Healthcare 0.39%
5 Financials 0.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OAIE
4601
DELISTED
Optimize AI Smart Sentiment Event-Driven ETF
OAIE
-11,862
Closed -$345K
ERSX
4602
DELISTED
ERShares NextGen Entrepreneurs ETF
ERSX
-12,784
Closed -$162K
ACAHW
4603
DELISTED
Atlantic Coastal Acquisition Corp. Warrant
ACAHW
-167,350
Closed -$4.35K
GRCL
4604
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
-25,144
Closed -$252K
BYOB
4605
DELISTED
Tidal ETF Trust SoFi Be Your Own Boss ETF
BYOB
-12,189
Closed -$233K
CHIS
4606
DELISTED
Global X MSCI China Consumer Staples ETF
CHIS
-12,097
Closed -$201K
CHIK
4607
DELISTED
Global X MSCI China Information Technology ETF
CHIK
-20,121
Closed -$305K
SJIM
4608
DELISTED
Inverse Cramer Tracker ETF
SJIM
-24,367
Closed -$527K
NVTA
4609
CALL
DELISTED
Invitae Corporation
NVTA
-95,800
Closed -$60.1K
NVTA
4610
DELISTED
Invitae Corporation
NVTA
-181,755
Closed -$114K
NVTA
4611
PUT
DELISTED
Invitae Corporation
NVTA
-217,400
Closed -$136K
RAIN
4612
DELISTED
Rain Oncology Inc. Common Stock
RAIN
-50,017
Closed -$60K
ORTX
4613
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
-15,000
Closed -$247K
MRTX
4614
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-24,300
Closed -$1.43M
MRTX
4615
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-47,716
Closed -$2.8M
MRTX
4616
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-14,800
Closed -$870K
TDSD
4617
DELISTED
Cabana Target Drawdown 13 ETF
TDSD
-34,146
Closed -$785K
TDSE
4618
DELISTED
Cabana Target Drawdown 16 ETF
TDSE
-29,970
Closed -$696K
CLSA
4619
DELISTED
Cabana Target Leading Sector Aggressive ETF
CLSA
-28,654
Closed -$555K
CLSC
4620
DELISTED
Cabana Target Leading Sector Conservative ETF
CLSC
-29,999
Closed -$581K
SLGC
4621
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
-15,575
Closed -$39.4K
CHS
4622
CALL
DELISTED
Chicos FAS, Inc.
CHS
-241,700
Closed -$1.83M
CHS
4623
PUT
DELISTED
Chicos FAS, Inc.
CHS
-13,600
Closed -$103K
LTHM
4624
CALL
DELISTED
Livent Corporation
LTHM
-66,800
Closed -$1.2M
LTHM
4625
DELISTED
Livent Corporation
LTHM
-48,071
Closed -$864K

Similar funds

GTS Securities's Q1 2024 Portfolio in Review

As of Q1 2024, GTS Securities held 4,632 positions worth $54.5B, down 7.2% from $58.7B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

GTS Securities withdrew a net $11.7B in Q1 2024, closing 864 positions and reducing 2,006 holdings. Its most notable exit was State Street Technology Select Sector SPDR ETF, an estimated $64.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 1.5% of assets, down from 1.5% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, GTS Securities opened a new position in Trip.com Group worth $22.9M.

  • GTS Securities's largest Q1 2024 buy was Trip.com Group: 521,822 shares worth $22.9M.
  • GTS Securities added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2024, an estimated $80.2M increase.
  • GTS Securities's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $180M.
  • GTS Securities fully exited State Street Technology Select Sector SPDR ETF in Q1 2024, selling an estimated $64.9M.
  • GTS Securities's ten largest holdings make up 43% of its $54.5B portfolio in Q1 2024.
  • GTS Securities opened 641 new positions and closed 864 in Q1 2024.
  • GTS Securities's portfolio value fell 7.2% quarter-over-quarter to $54.5B.

Based on GTS Securities's 13F filing for Q1 2024, filed 15 May 2024.